News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
The Journal of Experimental Medicine – Important roles of STAG2 in suppressing lung tumorigenesis
Lung Cancer/X
Dec 12, 2024, 20:39

The Journal of Experimental Medicine – Important roles of STAG2 in suppressing lung tumorigenesis

The Journal of Experimental Medicine shared on X:

“Emily Ashkin et al underscore important roles of STAG2 in suppressing lung tumorigenesis and highlight a STAG2-PAXIP1/PAGR1 tumor-suppressive program that may transcend cancer type. ”

The Journal of Experimental Medicine - Important roles of STAG2 in suppressing lung tumorigenesis

A STAG2-PAXIP1/PAGR1 axis suppresses lung tumorigenesis | Journal of Experimental Medicine | Rockefeller University Press

Authors: Emily L. Ashkin, Yuning J. Tang, Haiqing Xu, King L. Hung, Julia A. Belk, Hongchen Cai, Steven S. Lopez, Deniz Nesli Dolcen, Jess D. Hebert, Rui Li, Paloma A. Ruiz, Tula Keal, Laura Andrejka, Howard Y. Chang, Dmitri A. Petrov, Jesse R. Dixon, Zhichao Xu, Monte M. Winslow.

The Journal of Experimental Medicine - Important roles of STAG2 in suppressing lung tumorigenesis

cancer Deniz Nesli Dolcen Dmitri A. Petrov Emily Ashkin Emily L. Ashkin Haiqing Xu Hongchen Cai Howard Y. Chang Jess D. Hebert Jesse R. Dixon Julia A. Belk King L Hung Laura Andrejka Monte M. Winslow OncoDaily Oncology Paloma A. Ruiz Rui Li Steven S. Lopez The Journal of Experimental Medicine Tula Keal Yuning J. Tang Zhichao Xu
Special Coverage
Blog
Jun 3, 2025, 09:54
Robin Zon: ASCO 2025 President’s Address - “Driving Knowledge to Action: Building a Better Future”
Science
Jun 3, 2025, 09:52
Breaking research on GLP-1s and cancer from ASCO 2025
Blog
Jun 3, 2025, 09:48
Rami Manochakian: Results of ALNEO Phase 2 Trial at ASCO25
Blog
Jun 3, 2025, 09:33
Sagal Pannu: Tarlatamab and Emerging Bispecific T-cell Engagers Changing the Treatment Landscape of SCLC
Blog
Jun 3, 2025, 09:25
Nehemias Guevara-Rodriguez: Honored to Meet Saad Z. Usmani a Giant in Cancer Care
Blog
Jun 3, 2025, 09:15
Harold J. Burstein: First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
Blog
Jun 3, 2025, 09:06
Bishal Gyawali: Why Surrogate Endpoints Shouldn’t Justify Full Cancer Drug Approvals
Blog
Jun 3, 2025, 08:32
Memorial Sloan Kettering Cancer Center - New Hope for People with Stomach and Esophagus Cancer
Blog
Jun 3, 2025, 08:19
Neeraj Agarwal Highlights Promising T-Cell Engager Data in Prostate Cancer at ASCO 2025
Blog
Jun 3, 2025, 08:06
Nazik Hammad Expresses Gratitude to Mentees After ASCO Award Recognition
Blog
Jun 3, 2025, 08:01
Pramesh CS: Patient-Centered and Globally Relevant Research at ASCO 2025
Blog
Jun 3, 2025, 07:55
Jasmine Kamboj: Fantastic Time at Dr Robin Zon’s Presidential Reception